Repligen Valuation
| RGEN Stock | USD 161.47 3.27 1.98% |
At this time, the company appears to be undervalued. Repligen holds a recent Real Value of $190.24 per share. The prevailing price of the company is $161.47. Our model determines the value of Repligen from analyzing the company fundamentals such as Return On Equity of -0.0128, operating margin of 0.1 %, and Shares Outstanding of 56.03 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Repligen's valuation include:
Price Book 22.6457 | Enterprise Value | Enterprise Value Ebitda 88.0723 | Price Sales 14.548 | Forward PE 96.1538 |
Undervalued
Today
Please note that Repligen's price fluctuation is very steady at this time. Calculation of the real value of Repligen is based on 3 months time horizon. Increasing Repligen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Repligen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Repligen Stock. However, Repligen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 161.47 | Real 190.24 | Target 191.46 | Hype 162.11 | Naive 173.17 |
The intrinsic value of Repligen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Repligen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Repligen helps investors to forecast how Repligen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Repligen more accurately as focusing exclusively on Repligen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Repligen's intrinsic value based on its ongoing forecasts of Repligen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Repligen's closest peers.
Repligen Cash |
|
Repligen Valuation Trend
Knowing Repligen's actual value is paramount for traders when making sound investment determinations. Using both Repligen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Repligen Revenue by Product
Repligen Total Value Analysis
Repligen is at this time forecasted to have valuation of 9.11 B with market capitalization of 9.23 B, debt of 711.8 M, and cash on hands of 596.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Repligen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.11 B | 9.23 B | 711.8 M | 596.51 M |
Repligen Investor Information
About 94.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen recorded a loss per share of 0.46. The entity last dividend was issued on the 29th of October 2010. Based on the analysis of Repligen's profitability, liquidity, and operating efficiency, Repligen is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.Repligen Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Repligen suggests not a very effective usage of assets in February.Repligen Ownership Allocation
The majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company.Repligen Profitability Analysis
The company reported the previous year's revenue of 632.36 M. Net Income was 41.58 M with profit before overhead, payroll, taxes, and interest of 319.5 M.About Repligen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Repligen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Repligen based exclusively on its fundamental and basic technical indicators. By analyzing Repligen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Repligen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Repligen. We calculate exposure to Repligen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Repligen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 308.8 M | 533.9 M | |
| Pretax Profit Margin | 0.08 | 0.08 | |
| Operating Profit Margin | 0.07 | 0.07 | |
| Net Profit Margin | 0.05 | 0.05 | |
| Gross Profit Margin | 0.44 | 0.50 |
Repligen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 56.4 M | |
| Quarterly Earnings Growth Y O Y | -0.83 | |
| Forward Price Earnings | 96.1538 |
Repligen Current Valuation Indicators
Repligen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Repligen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Repligen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Repligen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Repligen's worth.When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (0.46) | Revenue Per Share | Quarterly Revenue Growth 0.006 | Return On Equity |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.